![James Hall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Hall
Chief Executive Officer at
Balticgruppen Bio AB
Health Technology
Profile
James Hall is Chief Executive Officer at Betagenon AB since 2021.
Formerly, Dr. Hall was Chief Executive Officer at Athera Biotechnologies AB from 2019 to 2021.
Dr. Hall also served as Chief Executive Officer at Amplifier TX AB.
James Hall active positions
| Companies | Position | Start |
|---|---|---|
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Chief Executive Officer | 2021-04-30 |
Former positions of James Hall
| Companies | Position | End |
|---|---|---|
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Chief Executive Officer | 2021-03-31 |
Amplifier TX AB
 Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Provides anti-inflammatory biological candidate drugs | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops activated protein kinase | Health Technology |
Amplifier TX AB
Amplifier TX AB BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops clinical molecule AMPK activators | Health Technology |
- Stock Market
- Insiders
- James Hall
